line_of_people

Report highlights that half of women in science face harassment

June 14, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical

Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …

apps_mobile

UK demand for mental health apps soars 566% since 2014

June 13, 2018
Medical Communications, Research and Development UK, apps, mental health, pharma

A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …

vaccination-2722937_960_720

Vaccination rates in parts of US fall to dangerous levels

June 13, 2018
Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination

The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …

celgene_1_02

Celgene showcases strong Otezla data in psoriatic arthritis

June 13, 2018
Research and Development Celgene, EULAR, otezla, pharma

Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …

J&J continues to shed assets, with $2.1bn diabetes unit sale

June 13, 2018
Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …

old_hands_stick

Investors stump up cash for anti-ageing start-up

June 12, 2018
Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical

Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …

brexit

Brexit negotiations: Is the public’s health a priority?

June 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …

dna-1903319_960_720

Research casts doubts over CRISPR safety

June 12, 2018
Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical

Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …

shutterstock_339308225

Vical terminates genital herpes vaccine after trial failure

June 12, 2018
Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma

San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …

allergan

Allergan’s atogepant fulfils primary endpoint in episodic migraine

June 12, 2018
Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma

Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …

nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018
Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …

handshake_2

Alexion goes back to roots with Complement deal

June 11, 2018
Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …

thumbs_up

AbbVie/Roche gain FDA approval for blockbuster treatment

June 11, 2018
Sales and Marketing AbbVie, Roche, biotech, drugs, pharma, pharmaceutical

AbbVie and Roche have a chalked up a major success, after the FDA gave its approval for Venclexta, in combination …

canada_block_001_takeda

Takeda shareholders try to buck Shire deal

June 11, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …

astrazeneca_logo_building

EU gives nod to expanded label for AZ’s Tagrisso

June 11, 2018
Sales and Marketing AstraZeneca, Tagrisso, biotech, drugs, pharma, pharmaceutical

AstraZeneca has scored another success with Tagrisso in Europe, by receiving an expanded marketing authorisation for Tagrisso in the first-line …

kendall_square_boston

Ipsen set to relocate North American HQ to Boston

June 11, 2018
Medical Communications, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen is set to join the ranks of a number of Boston-based biotechs, by setting up shop in Kendall Square. …

p_cagnoni_online

Rubius Therapeutics brings in new CEO

June 11, 2018
Medical Communications, Sales and Marketing Rubius Therapeutics, biotech, drugs, pharma, pharmaceutical

Rubius Therapeutics, a biotech that has ambitions to bring “super blood” to the market, has revealed that it has appointed …

top_ten

Top Ten most popular articles on Pharmafile.com this week

June 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

With ASCO occurring over the weekend, the headlines this week have been dominated by the news of breaking research that …

6.5% pay rise agreed for NHS staff

June 8, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

After years of receiving only a 1% annual pay rise, NHS staff have voted to accept a 6.5% pay offer increase …

pfizer_chrome_plate

Pfizer successfully appeals 2,600% price hiking case

June 8, 2018
Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …

The Gateway to Local Adoption Series

Latest content